<unk>  is an anthracycline and antineoplastic agent that is FDA approved for the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.   Common adverse reactions include alopecia, rash, urticaria, diarrhea, nausea, vomiting, stomach cramps and headache.
Idarubicin hydrochloride
Epirubicin hydrochloride
Pirarubicin
Amrubicin
Epirubicin
Valrubicin
Dihydroergocristine
Idoxuridine